Incannex Healthcare (IXHL) Operating Expenses (2022 - 2026)
Incannex Healthcare (IXHL) posted Operating Expenses of $4.0 million for Q1 2026, down 42.13% sequentially from $7.0 million in Q4 2025, and down 19.09% YoY from $5.0 million in Q1 2025.
Incannex Healthcare (IXHL) Operating Expenses (2022 - 2026) Analysis & Trends
Incannex Healthcare has reported Operating Expenses for 5 years, with the latest figure at $4.0 million in Q1 2026.
- Quarterly Operating Expenses fell 19.09% year-over-year to $4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.4 million (down 2.83% YoY) and the FY2025 annual result came in at $23.9 million, down 20.56% from the prior year.
- Operating Expenses slipped to $4.0 million in Q1 2026 per IXHL's latest filing, from $7.0 million in the prior quarter.
- Over five years, Operating Expenses peaked at $9.8 million in Q2 2024 and troughed at $3.6 million in Q4 2022.
- A 5-year average of $5.9 million and a median of $5.7 million in 2024 frame the typical range for Operating Expenses.
- The widest YoY moves for Operating Expenses: up 132.62% in 2024, down 37.17% in 2024.
- Over 5 years, Operating Expenses stood at $3.6 million in 2022, then soared by 119.37% to $8.0 million in 2023, then tumbled by 37.17% to $5.0 million in 2024, then jumped by 39.45% to $7.0 million in 2025, then tumbled by 42.13% to $4.0 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $4.0 million, $7.0 million, and $6.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Incannex Healthcare | 41.37 Mn | 41.37 Mn | - | 4.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.05 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Sep 30, 2025 | 6.79 Mn |
| Jun 30, 2025 | 7.53 Mn |
| Mar 31, 2025 | 5.00 Mn |
| Dec 31, 2024 | 5.02 Mn |
| Sep 30, 2024 | 6.33 Mn |
| Jun 30, 2024 | 9.76 Mn |
| Mar 31, 2024 | 7.42 Mn |
| Dec 31, 2023 | 7.98 Mn |
| Sep 30, 2023 | 4.89 Mn |
| Jun 30, 2023 | 4.19 Mn |
| Mar 31, 2023 | 3.65 Mn |
| Dec 31, 2022 | 3.64 Mn |